Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Nabiel Mir, MD
University of Chicago
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Illinois at Chicago (uic)
Chicago, Illinois, United States
Natalie Reizine, MDRecruiting - Uchicago Medicine Comprehensive Cancer Center
Chicago, Illinois, United States
Nabiel Mir, MDNot, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2026
- Primary completion
- 31 Dec 2026
- Completion
- 30 Jun 2027
- Last update posted
- 1 Oct 2025
- Registered enrollment
- 155
- Registry id
- NCT06824818
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.